# "Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC"

> **NCT03538717** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 157 (actual)

## Conditions studied

- Carcinoma, Renal Cell

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03538717
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-19
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-03-01
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03538717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03538717, ""Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC"". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03538717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*